Brean Capital Downgrades Itron (ITRI) to Hold

Go back to Brean Capital Downgrades Itron (ITRI) to Hold

Needham & Company Downgrades Itron (ITRI) to Hold

February 14, 2013 8:19 AM EST

Needham & Company downgraded Itron (NASDAQ: ITRI) from Buy to Hold following Q4 results and 2013 guidance.

The firm comments, "Overall, we view ITRI's 4Q results as communicating two stories to investors. The first is that the company is still a market leader with generally good... More

JPMorgan Downgrades Itron (ITRI) to Neutral

February 14, 2013 7:19 AM EST

JPMorgan downgraded Itron (NASDAQ: ITRI) from Overweight to Neutral with a price target of $45.50 (from $47.00) following Q4 results and outlook.

For an analyst ratings summary and ratings history on Itron click... More

Itron, Inc. (ITRI) Misses Q4 EPS by 8c; Guides Below

February 13, 2013 4:02 PM EST

Itron, Inc. (NASDAQ: ITRI) reported Q4 EPS of $0.58, $0.08 worse than the analyst estimate of $0.66. Revenue for the quarter came in at $523.3 million versus the consensus estimate of $472.88 million.

Itron, Inc. sees FY2013 EPS of $3.00-3.25, versus the consensus of $3.66.

For earnings... More